Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by bligickaon May 30, 2021 1:40pm
129 Views
Post# 33294216

Canadian cannabis company Hexo unveils its third and biggest

Canadian cannabis company Hexo unveils its third and biggestCanadian cannabis company Hexo unveils its third and biggest deal of the year so far Last Updated: May 28, 2021 at 2:56 p.m. ET First Published: May 28, 2021 at 1:27 p.m. ET By Ciara Linnane Hexo is buying family owned Redecan for $764.7 million in stock and cash as dizzying pace of M&A deals in the cannabis sector continues
<< Previous
Bullboard Posts
Next >>